We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JAKK:NASDAQJAKKS Pacific, Inc. Analysis

Data as of 2026-04-11 - not real-time

$21.82

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

JAKKS Pacific is trading above its short‑ and long‑term moving averages, and the MACD indicator has turned bullish, suggesting continued upward momentum. The RSI sits in the upper half of its range, reinforcing the strength of the current trend while still leaving room for further upside. Beta is notably high, indicating that price swings are amplified relative to the broader market, and the 30‑day volatility is elevated, which raises the risk profile. Volume has been on a downtrend, signaling waning participation that could limit the durability of the rally.
Fundamentally, the stock appears overvalued, with a discounted cash‑flow estimate far below the market price and a forward earnings multiple that implies limited growth expectations. Revenue is contracting and operating margins are negative, while free cash flow remains in the red, casting doubt on the sustainability of the generous dividend, whose payout exceeds earnings. The consumer‑cyclical sector exposes the company to economic swings, and the recent maximum drawdown highlights vulnerability during market stress.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical alignment (price above SMAs, MACD bullish)
  • Elevated beta and volatility increasing price risk
  • Dividend payout ratio above 100% raising sustainability concerns

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside relative to analyst price targets
  • Weak fundamentals (negative revenue growth, operating losses)
  • Decreasing trading volume limiting market depth

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation versus DCF fair value
  • Sustained negative cash flow and margins
  • High sensitivity to consumer‑cyclical downturns

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin1.73%
P/E Ratio25.4
ROE4.03%
ROA2.00%
Debt/Equity21.42
P/B Ratio1.0
Op. Cash Flow$8.5M
Free Cash Flow$-4910125

Technical Analysis

TrendBullish
RSI64.9
Support$19.11
Resistance$22.34
MA 20$20.32
MA 50$19.93
MA 200$18.49
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$6.93
Target Price$28.50
Upside/Downside30.61%
GradeOvervalued
TypeValue
Dividend Yield4.58%

Risk Assessment

Beta1.78
Volatility29.23%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.